“They very nicely showed that with this transitory system they could switch off this development gene briefly, switch it back on, and that was enough to trigger tumorigenesis,” said Douglas Hanahan, a ...

These challenges were unacceptable to Douglas Hanahan, currently director emeritus of the Swiss Institute for Experimental Cancer Research (ISREC) in the Swiss Federal Institute of Technology Lausanne ...

Oriol Casanovas, Douglas Hanahan and colleagues studied the response to VEGFA–VEGFR2 pathway inhibition of pancreatic neuroendocrine cancer in the RIP1-Tag2 mouse model and glioblastoma ...